Upland Resources Limited (LON:UPL)

Intercept Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	0.35	0.65	0.31	0.76	0.82
Cash & Short-Term Investments	0.35	0.65	0.31	0.76	0.82
Cash Growth	-46.53%	114.29%	-59.69%	-7.91%	-22.68%
Other Receivables	0	0	-	-	0.01
Receivables	0	0	-	-	0.01
Prepaid Expenses	0.04	0.03	0.01	0.01	0.01
Total Current Assets	0.39	0.69	0.31	0.77	0.83
Property, Plant & Equipment	0	0	-	-	-
Long-Term Investments	0.33	0.07	-	-	-
Long-Term Deferred Charges	-	-	-	-	0.08
Total Assets	4	1.34	0.31	0.77	0.91
Accounts Payable	0.12	0.11	0.15	0.13	0.15
Accrued Expenses	0.09	0.35	0.27	0.22	0.21
Short-Term Debt	-	-	0.15	0.15	-
Current Unearned Revenue	-	0.02	-	-	-
Other Current Liabilities	0.05	0.19	-	0.02	0.02
Total Current Liabilities	0.27	0.67	0.57	0.53	0.38
Total Liabilities	0.27	0.67	0.57	0.53	0.38
Common Stock	15.45	10.98	8.43	8.43	7.99
Retained Earnings	-12.25	-10.84	-8.69	-8.19	-7.45
Comprehensive Income & Other	0.52	0.52	-	-	-
Shareholders' Equity	3.73	0.66	-0.26	0.24	0.54
Total Liabilities & Equity	4	1.34	0.31	0.77	0.91
Total Debt	-	-	0.15	0.15	-
Net Cash (Debt)	0.35	0.65	0.16	0.61	0.82
Net Cash Growth	-46.53%	320.97%	-74.42%	-26.14%	-22.68%
Net Cash Per Share	0.00	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	1,370	1,195	686.77	686.77	619.63
Total Common Shares Outstanding	1,370	1,195	686.77	686.77	619.63
Working Capital	0.13	0.01	-0.26	0.24	0.46
Book Value Per Share	0.00	0.00	-0.00	0.00	0.00
Tangible Book Value	3.73	0.66	-0.26	0.24	0.54
Tangible Book Value Per Share	0.00	0.00	-0.00	0.00	0.00
Machinery	0	0	-	-	-

Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.